\-\ Texto\\:\\ \ \(0\)\
\-\ colloid\\ cyst\\ was\\ resected\\ given\\ pt\\'s\\ acute\\ presentation\\.\ \(0\)\
\-\ noncontrast\\ ct\\ of\\ the\\ head\\ demonstrates\\ a\\ well\\-circumscribed\\ hyperdense\\ mass\\ in\\ the\\ anterior\\ portion\\ of\\ third\\ ventricle\\ in\\ the\\ region\\ of\\ foramen\\ of\\ monroe\\.\\ there\\ is\\ asymmetric\\ enlargement\\ of\\ the\\ right\\ ventricle\\ suggestive\\ of\\ hydrocephalus\\.\ \(0\)\
\-\ mr\\ images\\ demonstrate\\ a\\ well\\-circumscribed\\ mass\\ in\\ the\\ anterior\\ portion\\ of\\ the\\ third\\ ventricle\\ at\\ the\\ foramen\\ of\\ monroe\\ that\\ is\\ hyperintense\\ on\\ t1\\,\\ mildly\\ hyperintense\\ on\\ t2\\ and\\ demonstrates\\ some\\ peripheral\\ rim\\ enhancement\\ on\\ post\\ contrast\\ images\\.\ \(0\)\
\-\ colloid\\ cyst\\ of\\ the\\ third\\ ventricle\ \(0\)\
\-\ colloid\\ cyst\ \(15\)\
\-\ central\\ neurocytoma\ \(3\)\
\-\ gliomas\\ \\(subependymal\\ giant\\ cell\\ tumor\\ in\\ tuberous\\ sclerosis\\,\\ pilocytic\\ astrocytoma\\,\\ oligodendrogliomas\\)\ \(0\)\
\-\ craniopharyngioma\ \(24\)\
\-\ choroid\\ plexus\\ papilloma\ \(11\)\
\-\ vascular\\ tumors\ \(5\)\
\-\ cysticercosis\ \(25\)\
\-\ 27yo\\ white\\ man\\ presents\\ to\\ the\\ emergency\\ room\\ with\\ acute\\ onset\\ of\\ headache\\.\ \(1\)\
\-\ likely\\ colloid\\ cyst\\ given\\ the\\ signal\\ characteristics\\ of\\ hyperdense\\ on\\ ct\\,\\ hyperintense\\ on\\ t1\\,\\ slightly\\ hyperintense\\ on\\ t2\\ and\\ rim\\ enhancement\\.\\ \\ rim\\ enhancement\\ is\\ seen\\ in\\ 40\\%\\ of\\ cases\\.\\ \\ dense\\ enhancement\\ would\\ suggest\\ a\\ lesion\\ other\\ than\\ colloid\\ cyst\\.\ \(0\)\
\-\ central\\ neurocytoma\\ \\-\\ intraventricular\\,\\ benign\\,\\ slow\\ growing\\ hypervascular\\ tumors\\,\\ commonly\\ in\\ the\\ lateral\\ ventricle\\,usually\\ attached\\ to\\ septum\\ pellucidum\\ at\\ fm\\ and\\ mimic\\ oligodendroglioma\\ on\\ histology\\.\\ predilection\\ for\\ young\\ females\\.\\ hyperdense\\ on\\ ct\\,\\ isointense\\ to\\ gray\\ matter\\ on\\ t1wi\\,\\ 50\\%\\ calcify\\ and\\ enhances\\ brightly\\ but\\ inhomogeneously\\.\\ \ \(0\)\
\-\ craniopharyngioma\\ \\-\\ 2nd\\ most\\ common\\ mass\\ in\\ third\\ ventricle\\,most\\ are\\ suprasellar\\,\\ usually\\ in\\ 5\\-10\\ or\\ \\>50\\ yr\\ old\\ patients\\,\\ solid\\ and\\ cystic\\ lesions\\ containing\\ cholestrol\\ crystals\\.\\ ct\\ \\-\\>\\ large\\ cystic\\ mass\\,\\ enhancing\\ rim\\ and\\ some\\ calcification\\.\\ mr\\-\\>\\ classically\\,\\ cystic\\ portion\\ is\\ hyperintense\\ on\\ t1\\ and\\ t2\\.\\ most\\ have\\ calcification\\ or\\ enhancing\\ rim\\.\ \(0\)\
\-\ choroid\\ plexus\\ papilloma\\ \\-\\ rare\\ neuroepithelial\\ tumor\\ most\\ common\\ in\\ first\\ decade\\,\\ commonly\\ seen\\ in\\ atrium\\ of\\ lateral\\ ventricle\\ in\\ children\\ and\\ 4th\\ ventricle\\ in\\ adults\\.\\ iii\\ ventricle\\ next\\ common\\ site\\.\\ highly\\ vascular\\ tumors\\.\\ 10\\-20\\%\\ show\\ malignant\\ degeneration\\.\\ ct\\-\\>iso\\-hyperdense\\,\\ shape\\ of\\ cauliflower\\ with\\ choroid\\ plexus\\ calcification\\.\\ \\ mr\\-\\>\\ isointense\\ to\\ gray\\ matter\\ on\\ t1\\,\\ hyperintense\\ on\\ t2\\ and\\ enhance\\ markedly\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ventricle\\:\\ 0\\.07768601848573005\ \(0\)\
\-\ colloid\\:\\ 0\\.06780766563407328\ \(0\)\
\-\ hyperintense\\:\\ 0\\.057374559540213\ \(0\)\
\-\ rim\\:\\ 0\\.048746919039092625\ \(0\)\
\-\ monroe\\:\\ 0\\.03884679521041724\ \(0\)\
\-\ \\>\\:\\ 0\\.03826371313569494\ \(0\)\
\-\ mr\\-\\:\\ 0\\.037032928705720676\ \(0\)\
\-\ third\\:\\ 0\\.036942821500269514\ \(0\)\
\-\ choroid\\:\\ 0\\.03526553472544197\ \(0\)\
\-\ hyperdense\\:\\ 0\\.03454628281695279\ \(0\)\
\-\ plexus\\:\\ 0\\.03357476547052101\ \(0\)\
\-\ cyst\\:\\ 0\\.03094839805965098\ \(0\)\
\-\ t1\\:\\ 0\\.029202108207269477\ \(0\)\
\-\ neurocytoma\\:\\ 0\\.02918771451377004\ \(0\)\
\-\ t2\\:\\ 0\\.026076428773588702\ \(0\)\
\-\ tumors\\:\\ 0\\.025954579711621302\ \(0\)\
\-\ calcification\\:\\ 0\\.025081824408009133\ \(0\)\
\-\ portion\\:\\ 0\\.02502862518080124\ \(0\)\
\-\ enhancement\\:\\ 0\\.024695296669790145\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.024393848963979017\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.024393848963979017\ \(0\)\
\-\ oligodendrogliomas\\:\\ 0\\.02376150518589353\ \(0\)\
\-\ cholestrol\\:\\ 0\\.02376150518589353\ \(0\)\
\-\ iso\\-hyperdense\\:\\ 0\\.02376150518589353\ \(0\)\
\-\ on\\:\\ 0\\.023414264550903334\ \(0\)\
\-\ papilloma\\:\\ 0\\.023146791627587374\ \(0\)\
\-\ isointense\\:\\ 0\\.022643654485850345\ \(0\)\
\-\ gray\\:\\ 0\\.022537948440629986\ \(0\)\
\-\ foramen\\:\\ 0\\.021990943264539098\ \(0\)\
\-\ cauliflower\\:\\ 0\\.021893183944492058\ \(0\)\
\-\ most\\:\\ 0\\.02127045974908977\ \(0\)\
\-\ 27yo\\:\\ 0\\.020800286078971397\ \(0\)\
\-\ inhomogeneously\\:\\ 0\\.020800286078971397\ \(0\)\
\-\ fm\\:\\ 0\\.020024862703090587\ \(0\)\
\-\ cystic\\:\\ 0\\.01992964453303309\ \(0\)\
\-\ \\-\\:\\ 0\\.019749093894429796\ \(0\)\
\-\ brightly\\:\\ 0\\.01942339760520862\ \(0\)\
\-\ matter\\:\\ 0\\.018137358331001607\ \(0\)\
\-\ common\\:\\ 0\\.01808302327727545\ \(0\)\
\-\ 50\\:\\ 0\\.01752559577705555\ \(0\)\
\-\ commonly\\:\\ 0\\.017382918832644968\ \(0\)\
\-\ 10\\-20\\:\\ 0\\.017298175609617595\ \(0\)\
\-\ crystals\\:\\ 0\\.016648143111458867\ \(0\)\
\-\ \\%\\:\\ 0\\.016118498921935374\ \(0\)\
\-\ calcify\\:\\ 0\\.0159707457306478\ \(0\)\
\-\ 5\\-10\\:\\ 0\\.01582501198059315\ \(0\)\
\-\ given\\:\\ 0\\.015791991334319907\ \(0\)\
\-\ neuroepithelial\\:\\ 0\\.015555245245938208\ \(0\)\
\-\ ct\\-\\:\\ 0\\.015310038296596627\ \(0\)\
\-\ gliomas\\:\\ 0\\.015195322354766987\ \(0\)\
\-\ predilection\\:\\ 0\\.015195322354766987\ \(0\)\
\-\ central\\:\\ 0\\.015157042355040212\ \(0\)\
\-\ vascular\\:\\ 0\\.015104060743523972\ \(0\)\
\-\ yr\\:\\ 0\\.015085290024523712\ \(0\)\
\-\ pellucidum\\:\\ 0\\.01459385725688502\ \(0\)\
\-\ mimic\\:\\ 0\\.014505474985124939\ \(0\)\
\-\ enhancing\\:\\ 0\\.014447188856521614\ \(0\)\
\-\ cysticercosis\\:\\ 0\\.014336956502695467\ \(0\)\
\-\ t1wi\\:\\ 0\\.01417835677217543\ \(0\)\
\-\ some\\:\\ 0\\.013988831557233202\ \(0\)\
\-\ usually\\:\\ 0\\.013988831557233202\ \(0\)\
\-\ \\,\\:\\ 0\\.013863857802772129\ \(0\)\
\-\ subependymal\\:\\ 0\\.013751876973752535\ \(0\)\
\-\ attached\\:\\ 0\\.013686924004536739\ \(0\)\
\-\ histology\\:\\ 0\\.013686924004536739\ \(0\)\
\-\ in\\:\\ 0\\.0136300990880945\ \(0\)\
\-\ hypervascular\\:\\ 0\\.01362349948321546\ \(0\)\
\-\ decade\\:\\ 0\\.013561533126814655\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.013500959391364364\ \(0\)\
\-\ classically\\:\\ 0\\.013441717055195158\ \(0\)\
\-\ intraventricular\\:\\ 0\\.0133837488470524\ \(0\)\
\-\ atrium\\:\\ 0\\.012960068028932688\ \(0\)\
\-\ ct\\:\\ 0\\.012887370926059762\ \(0\)\
\-\ females\\:\\ 0\\.012816914860970564\ \(0\)\
\-\ mass\\:\\ 0\\.012813595762237893\ \(0\)\
\-\ growing\\:\\ 0\\.012725536015483553\ \(0\)\
\-\ tuberous\\:\\ 0\\.012680982640951986\ \(0\)\
\-\ suprasellar\\:\\ 0\\.012551577737484707\ \(0\)\
\-\ slow\\:\\ 0\\.012468635261293996\ \(0\)\
\-\ noncontrast\\:\\ 0\\.01231003553077396\ \(0\)\
\-\ pilocytic\\:\\ 0\\.012124070917601586\ \(0\)\
\-\ shape\\:\\ 0\\.011984017712936596\ \(0\)\
\-\ anterior\\:\\ 0\\.011864112257481066\ \(0\)\
\-\ septum\\:\\ 0\\.011786703955461407\ \(0\)\
\-\ adults\\:\\ 0\\.01175517824181399\ \(0\)\
\-\ containing\\:\\ 0\\.011693211885413186\ \(0\)\
\-\ next\\:\\ 0\\.011693211885413186\ \(0\)\
\-\ degeneration\\:\\ 0\\.011693211885413186\ \(0\)\
\-\ 4th\\:\\ 0\\.011602854224931668\ \(0\)\
\-\ 2nd\\:\\ 0\\.011486904399908243\ \(0\)\
\-\ characteristics\\:\\ 0\\.011458679871964049\ \(0\)\
\-\ resected\\:\\ 0\\.011403102278425677\ \(0\)\
\-\ acute\\:\\ 0\\.011374012555830164\ \(0\)\
\-\ asymmetric\\:\\ 0\\.01119158849017367\ \(0\)\
\-\ enhance\\:\\ 0\\.011141205382324201\ \(0\)\
\-\ giant\\:\\ 0\\.011091746787531219\ \(0\)\
\-\ highly\\:\\ 0\\.011091746787531219\ \(0\)\
\-\ markedly\\:\\ 0\\.010902516979786612\ \(0\)\
\-\ dense\\:\\ 0\\.010879770703113124\ \(0\)\
\-\ enhances\\:\\ 0\\.010879770703113124\ \(0\)\
\-\ iii\\:\\ 0\\.010812661399550517\ \(0\)\
\-\ tumor\\:\\ 0\\.010739796774182271\ \(0\)\
\-\ demonstrates\\:\\ 0\\.010062647987348712\ \(0\)\
\-\ young\\:\\ 0\\.010031720278058587\ \(0\)\
\-\ lateral\\:\\ 0\\.009955083803905933\ \(0\)\
\-\ children\\:\\ 0\\.009950281521733799\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.00990257376674889\ \(0\)\
\-\ room\\:\\ 0\\.00990257376674889\ \(0\)\
\-\ suggestive\\:\\ 0\\.009840249191490524\ \(0\)\
\-\ mildly\\:\\ 0\\.009809619114265955\ \(0\)\
\-\ suggest\\:\\ 0\\.009809619114265955\ \(0\)\
\-\ site\\:\\ 0\\.009734532983530197\ \(0\)\
\-\ 40\\:\\ 0\\.009690465226113675\ \(0\)\
\-\ slightly\\:\\ 0\\.009310582906353296\ \(0\)\
\-\ solid\\:\\ 0\\.009186918200825822\ \(0\)\
\-\ enlargement\\:\\ 0\\.009138998400229368\ \(0\)\
\-\ seen\\:\\ 0\\.009103113827858169\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.008944340158149046\ \(0\)\
\-\ rare\\:\\ 0\\.008944340158149046\ \(0\)\
\-\ images\\:\\ 0\\.008837002112934523\ \(0\)\
\-\ emergency\\:\\ 0\\.008721802150890232\ \(0\)\
\-\ pt\\:\\ 0\\.008563783705209577\ \(0\)\
\-\ peripheral\\:\\ 0\\.008334052080900586\ \(0\)\
\-\ malignant\\:\\ 0\\.008325257887814828\ \(0\)\
\-\ sclerosis\\:\\ 0\\.008273086882550795\ \(0\)\
\-\ would\\:\\ 0\\.008196676222161968\ \(0\)\
\-\ benign\\:\\ 0\\.007948922822191918\ \(0\)\
\-\ presentation\\:\\ 0\\.007933694432590519\ \(0\)\
\-\ headache\\:\\ 0\\.007911011961093796\ \(0\)\
\-\ first\\:\\ 0\\.007729065861956475\ \(0\)\
\-\ cases\\:\\ 0\\.007673344646849414\ \(0\)\
\-\ white\\:\\ 0\\.007639094912970399\ \(0\)\
\-\ mr\\:\\ 0\\.007318596959424351\ \(0\)\
\-\ onset\\:\\ 0\\.007270677158827898\ \(0\)\
\-\ post\\:\\ 0\\.007252924617445536\ \(0\)\
\-\ show\\:\\ 0\\.007070501171136458\ \(0\)\
\-\ head\\:\\ 0\\.006532618087800259\ \(0\)\
\-\ region\\:\\ 0\\.006505663685281166\ \(0\)\
\-\ likely\\:\\ 0\\.006496738452656756\ \(0\)\
\-\ at\\:\\ 0\\.0062413107969360275\ \(0\)\
\-\ cell\\:\\ 0\\.006221673077039047\ \(0\)\
\-\ lesions\\:\\ 0\\.006165931283945951\ \(0\)\
\-\ signal\\:\\ 0\\.0060729766314630155\ \(0\)\
\-\ is\\:\\ 0\\.006062434268298929\ \(0\)\
\-\ than\\:\\ 0\\.006035172115682679\ \(0\)\
\-\ patients\\:\\ 0\\.005961117518506809\ \(0\)\
\-\ man\\:\\ 0\\.005447255641752019\ \(0\)\
\-\ or\\:\\ 0\\.005399044468807049\ \(0\)\
\-\ other\\:\\ 0\\.0053089987835645515\ \(0\)\
\-\ demonstrate\\:\\ 0\\.005300410084455635\ \(0\)\
\-\ contrast\\:\\ 0\\.005155729614037481\ \(0\)\
\-\ \\'s\\:\\ 0\\.005078292771878828\ \(0\)\
\-\ large\\:\\ 0\\.005036502511674069\ \(0\)\
\-\ have\\:\\ 0\\.004987703715269789\ \(0\)\
\-\ but\\:\\ 0\\.004912407819497406\ \(0\)\
\-\ presents\\:\\ 0\\.004705240688700609\ \(0\)\
\-\ lesion\\:\\ 0\\.00469152352021686\ \(0\)\
\-\ to\\:\\ 0\\.004604507907741092\ \(0\)\
\-\ of\\:\\ 0\\.004396369841433525\ \(0\)\
\-\ and\\:\\ 0\\.004366795287304491\ \(0\)\
\-\ the\\:\\ 0\\.004099035395525293\ \(0\)\
\-\ that\\:\\ 0\\.003978384713096559\ \(0\)\
\-\ there\\:\\ 0\\.003427804734406978\ \(0\)\
\-\ a\\:\\ 0\\.0032070064837083664\ \(0\)\
\-\ are\\:\\ 0\\.003139821758839897\ \(0\)\
\-\ was\\:\\ 0\\.002663820814592148\ \(0\)\
\-\ right\\:\\ 0\\.0024302741485455978\ \(0\)\
\-\ old\\:\\ 0\\.0023583142772567512\ \(0\)\
\-\ \\.\\:\\ 0\\.002009407703623374\ \(0\)\
\-\ for\\:\\ 0\\.001965251074508666\ \(0\)\
\-\ \\(\\:\\ 0\\.0019470666475575756\ \(0\)\
\-\ \\)\\:\\ 0\\.0019232821889846499\ \(0\)\
\-\ with\\:\\ 0\\.0006307502754171954\ \(0\)\
